IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Homology Medicines Inc

CUSIP: 438083107 | 300 institutional holders

Quarters

Q2 2026Q1 2026Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Kerr Financial Planning Corp600
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Kerr Financial Planning Corp
600$10.0%GrowthMediumFresno, CA2026-07-02